Serology for human papillomavirus

被引:0
作者
Coursaget, P [1 ]
机构
[1] Fac Pharm Ph Manupas, Mol Virol Lab, F-37200 Tours, France
来源
SALUD PUBLICA DE MEXICO | 2003年 / 45卷
关键词
cervical cancer; VLP; HPV; serology;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Difficulties with serology for papillomavirus are associated with the large number of human papillomavirus, cross-reactions between papillomavirus, and to the diversity of lesions and target sites for infection. In addition, the expression of the papillomavirus in the superficial layers of the epithelium gives rise to the weak presentation to immunocompetent cells of viral antigens,which in turn gives rise to a weak serological response. Distinct efforts have been made in previous decades to develop more specific and sensitive serological assays. These former studies use fusion proteins and synthetic peptides, although they remain on the whole uninteresting, due to their lack of sensitivity and specificity. Only in the last few years, and principally due to the advent of various virus-like particles (VLP), have more sensitive and specific assays become available.
引用
收藏
页码:S361 / S366
页数:6
相关论文
共 87 条
  • [1] af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428
  • [2] Af Geijersstam V, 1999, INT J CANCER, V80, P489, DOI 10.1002/(SICI)1097-0215(19990209)80:4<489::AID-IJC1>3.0.CO
  • [3] 2-9
  • [4] Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls - A longitudinal cohort study
    AnderssonEllstrom, A
    Dillner, J
    Hagmar, B
    Schiller, J
    Sapp, M
    Forssman, L
    Milsom, I
    [J]. SEXUALLY TRANSMITTED DISEASES, 1996, 23 (03) : 234 - 238
  • [5] EXPRESSION OF HUMAN PAPILLOMAVIRUS TYPE-6 AND TYPE-16 CAPSID PROTEINS IN BACTERIA AND THEIR ANTIGENIC CHARACTERIZATION
    BANKS, L
    MATLASHEWSKI, G
    PIM, D
    CHURCHER, M
    ROBERTS, C
    CRAWFORD, L
    [J]. JOURNAL OF GENERAL VIROLOGY, 1987, 68 : 3081 - 3089
  • [6] The pharmacokinetics of factor VIII and factor IX: Methodology, pitfalls and applications
    Bjorkman, S
    Carlsson, M
    [J]. HAEMOPHILIA, 1997, 3 (01) : 1 - 8
  • [7] HUMAN PAPILLOMAVIRUS TYPE-18 E6 AND E7 ANTIBODIES IN HUMAN SERA - INCREASED ANTI-E7 PREVALENCE IN CERVICAL-CANCER PATIENTS
    BLEUL, C
    MULLER, M
    FRANK, R
    GAUSEPOHL, H
    KOLDOVSKY, U
    MGAYA, HN
    LUANDE, J
    PAWLITA, M
    TERMEULEN, J
    VISCIDI, R
    GISSMANN, L
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (08) : 1579 - 1588
  • [8] Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia II. Systemic but not local IgA responses correlate with clearance of HPV-16
    Bontkes, HJ
    de Gruijl, TD
    Walboomers, JMM
    Schiller, JT
    Dillner, J
    Helmerhorst, TJM
    Verheijen, RHM
    Scheper, RJ
    Meijer, CJLM
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 409 - 417
  • [9] Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions
    Bousarghin, L
    Combita-Rojas, AL
    Touzé, A
    El Mehdaoui, S
    Sizaret, PY
    Bravo, MM
    Coursaget, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 926 - 932
  • [10] The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women
    Carter, JJ
    Koutsky, LA
    Wipf, GC
    Christensen, ND
    Lee, SK
    Kuypers, J
    Kiviat, N
    Galloway, DA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) : 927 - 936